The Biotech Startups Podcast

🧬 Michael Paliotti: Blending Science, Sales, and Side Hustles in Biotech (Part 3/4)

24 Mar 2025

Contributed by Lukas

“Trust takes time—but it lasts longer than any sale.” In part three of our conversation with Michael Paliotti, we dive into his transition from...

🧬 Michael Paliotti: Navigating Biotech Careers & Building Lasting Relationships (Part 2/4)

20 Mar 2025

Contributed by Lukas

🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equi...

🧬 Michael Paliotti: Navigating a Winding Path to Biotech Success (Part 1/4)

17 Mar 2025

Contributed by Lukas

"Growing up in a science-driven environment influenced my trajectory, from my father's chemistry background at Kodak to my own experiences in academia...

🧬 Stavros Papadopoulos: Transforming Data Management (Part 4/4)

13 Mar 2025

Contributed by Lukas

In this final part of our conversation with Stavros, founder and CEO of TileDB, we explore the challenges and opportunities in transforming data manag...

🧬 Stavros Papadopoulos: Scaling TileDB & Revolutionizing Data Infrastructure (Part 3/4)

10 Mar 2025

Contributed by Lukas

"We're wasting money. You're wasting money as an organization, like, hundreds of millions of dollars that can save you that money easily. But you have...

🧬Stavros Papadopoulos: How Serendipity Sparked TileDB's Startup Journey (Part 2/4)

06 Mar 2025

Contributed by Lukas

"Serendipity plays a big role, but you need to chase it, man. You need to [chase it] and you need to perform. You need to deliver [on] your end of the...

🧬 Stavros Papadopoulos: A Journey in Computer Science & Data Management (Part 1/4)

03 Mar 2025

Contributed by Lukas

"If you are capable of acquiring knowledge, of applying the knowledge, and you like it, you can succeed. It doesn't matter what it is." In this episo...

🧬 Becky Beattie: Scaling LaunchBio & Democratizing Biotech Entrepreneurship (Part 2/2)

27 Feb 2025

Contributed by Lukas

"If I'm not building something, then I'm probably not going to be doing it for long. That's the fun part." In part two of our conversation with Becky...

🧬 Becky Beattie: From Rural Beginnings to Building a National Biotech Network (Part 1)

24 Feb 2025

Contributed by Lukas

In part one of our conversation with Becky Beattie, CEO of LaunchBio, we trace her unconventional path from rural San Jose pig farmer to biotech ecosy...

🧬 Dr. Kate Yen: Scaling a Biotech, Running Lean, & Utilizing Translational Biology (Part 2)

20 Feb 2025

Contributed by Lukas

“I didn’t set out to be an entrepreneur, but when I couldn’t find a company doing what I believed in, I built my own.” In part two of our con...

🧬 Kate Yen - Part 1 | From Academia to Biotech Leader | Translating Research into Cancer Therapies | Early Days at Merck & Agios

17 Feb 2025

Contributed by Lukas

Part 1 of 2: Our guest today is Kate Yen, Founder and CEO of Auron Therapeutics. Auron Therapeutics leverages cutting-edge science and AI-powered anal...

🧬 Oguzhan Atay - Part 2 | From Immigrant to Biotech Innovator | Battling Deportation with Nobel Laureate Support | Building a $140M Prenatal Testing Empire

13 Feb 2025

Contributed by Lukas

Part 2 of 2: Our guest today is Oguzhan Atay, Co-founder & CEO of BillionToOne. BillionToOne is a precision diagnostics company that quantifies biolog...

🧬 Oguzhan Atay - Part 1 | From Small-Town Turkey to Stanford PhD | Solving Cell Cycle Mysteries | Building a Biotech During a Global Pandemic

10 Feb 2025

Contributed by Lukas

Part 1 of 2: Our guest today is Oguzhan Atay, Co-founder & CEO of BillionToOne. BillionToOne is a precision diagnostics company that quantifies biolog...

🧬 Parag Shah - Part 2 | Scaling a Multi-Billion Dollar Life Sciences Fund | Culture, Capital & Entrepreneurship | The K2 HealthVentures Story

06 Feb 2025

Contributed by Lukas

Part 2 of 2: Our guest today is Parag Shah, CEO and Founding Managing Director of K2 HealthVentures. K2 HealthVentures is an alternative investment fi...

🧬 Parag Shah - Part 1 | Rethinking Biotech Startup Funding | Building Smarter Capital Strategies | Risk, Reward & Leadership in Investing

03 Feb 2025

Contributed by Lukas

Part 1 of 2: Our guest today is Parag Shah, CEO and Founding Managing Director of K2 HealthVentures. K2 HealthVentures is an alternative investment fi...

🧬 Jason C. Foster - Part 2 | Manufacturing Brighter Futures | From Richmond to London: Building a Biotech Empire | Culture Eats Strategy for Breakfast

30 Jan 2025

Contributed by Lukas

Part 2 of 2: My guest today is Jason C. Foster, CEO and Executive Director of Ori Biotech. Ori is revolutionizing Cell and Gene Therapy manufacturing ...

🧬 Jason C. Foster - Part 1 | From Paper Routes to Pharma | Navigating the Dot-Com Bubble | Building a $1B Addiction Medicine Business in 4 Years

27 Jan 2025

Contributed by Lukas

Part 1 of 2: My guest today is Jason C. Foster, CEO and Executive Director of Ori Biotech. Ori is revolutionizing Cell and Gene Therapy manufacturing ...

🧬 Rafael Rosengarten - Part 4 | Lessons in Scaling a Biotech Startup | Using AI to Transform Cancer Diagnostics | The Genialis Supermodel & krasID

23 Jan 2025

Contributed by Lukas

Part 4 of 4: My guest today is Rafael Rosengarten, CEO and Co-Founder of Genialis, the RNA biomarker company. Genialis is reimagining biomarkers for e...

🧬 Rafael Rosengarten - Part 3 | Leveraging AI in Precision Medicine | How Predictive Biomarkers Transform Oncology | Lessons from Scaling a Startup

20 Jan 2025

Contributed by Lukas

Part 3 of 4: My guest today is Rafael Rosengarten, CEO and Co-Founder of Genialis, the RNA biomarker company. Genialis is reimagining biomarkers for e...

🧬 Rafael Rosengarten - Part 2 | From Marine Biology to Synthetic Biology | Building Biofuel Tools at JBEI | When Academic Labs Embrace Entrepreneurship

16 Jan 2025

Contributed by Lukas

Part 2 of 4: My guest today is Rafael Rosengarten, CEO and Co-Founder of Genialis, the RNA biomarker company. Genialis is reimagining biomarkers for e...

🧬 Rafael Rosengarten - Part 1 | From Salt Marsh to Biotech CEO | Snorkeling into Science | Choosing Marine Biology Over Cooking on a Mediterranean Yacht

13 Jan 2025

Contributed by Lukas

Part 1 of 4: My guest today is Rafael Rosengarten, CEO and Co-Founder of Genialis, the RNA biomarker company. Genialis is reimagining biomarkers for e...

🧬 Cyriac Roeding - Part 4 | Revolutionizing Cancer Detection & Therapy | Harnessing Synthetic Biology to Reshape Diagnostics | Solving Biotech’s Toughest Problems

09 Jan 2025

Contributed by Lukas

Part 4 of 4: My guest today is Cyriac Roeding, founder, investor, and CEO of Earli, a company on a mission to transform cancer into a manageable condi...

🧬Cyriac Roeding - Part 3 | Founding Shopkick During the 2008 Financial Crisis | Transforming Retail with Mobile Tech | Exploring AI’s Use in Clinical Trials & Reshaping Drug Development

06 Jan 2025

Contributed by Lukas

Part 3 of 4: My guest today is Cyriac Roeding, founder, investor, and CEO of Earli, a company on a mission to transform cancer into a manageable condi...

🧬 Cyriac Roeding - Part 2 | From Digital Clocks to Global Mobile Marketing | Cracking Coca-Cola's 160 Million Bottle Code | Silicon Valley's Pine-Scented Entrepreneurship | Leapfrogging Technology in the Amazon Jungle

02 Jan 2025

Contributed by Lukas

Part 2 of 4: My guest today is Cyriac Roeding, founder, investor, and CEO of Earli, a company on a mission to transform cancer into a manageable condi...

🧬 Cyriac Roeding - Part 1 | From Flea Market Entrepreneur to Silicon Valley CEO | Reinvention During an Exchange Year | Finding Perspective in Japanese Business Culture

30 Dec 2024

Contributed by Lukas

Part 1 of 4: My guest today is Cyriac Roeding, founder, investor, and CEO of Earli, a company on a mission to transform cancer into a manageable condi...

🧬 Kate Neville - Part 4 | Balancing IP Enforcement & Licensing | Leveraging Shelved Pharma Assets | Building Resilient IP Portfolios

19 Dec 2024

Contributed by Lukas

Part 4 of 4: In this episode, Jon Chee hosts Kate Neville, PhD, Partner at Marshall Gerstein—a law firm with over 60 years of expertise in deliverin...

🧬Kate Neville - Part 3 | Fundamentals of IP Strategy for Biotechs | Safeguarding Discoveries & Technology | Aligning Science with Patents | Navigating Global Patent Considerations

16 Dec 2024

Contributed by Lukas

Part 3 of 4: In this episode, Jon Chee hosts Kate Neville, PhD, Partner at Marshall Gerstein—a law firm with over 60 years of expertise in deliverin...

🧬Kate Neville - Part 2 | Navigating Law School as a Scientist | From Patent Agent to Lawyer | Thriving at the Intersection of Science & Law | Continuous Learning in Diverse Scientific Fields

12 Dec 2024

Contributed by Lukas

Part 2 of 4: Jon Chee hosts Kate Neville, Partner at Marshall Gerstein—a law firm with over 60 years of expertise in delivering sophisticated intell...

🧬 Kate Neville - Part 1 | From Youngest of Six to Patent Law Pioneer | When Chemistry Sets Spark Scientific Careers | Leading Through Autonomy | Serendipitous Path from Lab Bench to IP Law

09 Dec 2024

Contributed by Lukas

Part 1 of 4: Jon Chee hosts Kate Neville, Partner at Marshall Gerstein—a law firm with over 60 years of expertise in delivering sophisticated intell...

🧬 Barry Ticho - Part 4 | Founding Verve Therapeutics Over Breakfast | Gene Editing for Cardiovascular Disease | Leadership Lessons From a First-Time Founder | Stoke’s Vision for RNA-Based Medicines

05 Dec 2024

Contributed by Lukas

Part 4 of 4: Jon Chee hosts Barry Ticho, Founder of Verve Therapeutics and Chief Medical Officer at Stoke Therapeutics, a biotech company addressing t...

🧬 Barry Ticho - Part 3 | Lessons From Rigorous Drug Development | Industry vs. Academic Research Standards | A Patient-Centered Approach to Clinical Trials | How RNA is Shaping Modern Medicine

02 Dec 2024

Contributed by Lukas

Part 3 of 4: Jon Chee hosts Barry Ticho, Founder of Verve Therapeutics and Chief Medical Officer at Stoke Therapeutics, a biotech company addressing t...

🧬Barry Ticho - Part 2 | Zebrafish Hearts & Pediatric Cardiology | Balancing Lab Work & Clinical Practice | Navigating Academic Medicine's Challenges | The Draw of Biopharma & Translational Medicine

28 Nov 2024

Contributed by Lukas

Part 2 of 4: Jon Chee hosts Barry Ticho, Founder of Verve Therapeutics and Chief Medical Officer at Stoke Therapeutics, a biotech company addressing t...

🧬Barry Ticho - Stoke Therapeutics - Part 1 | From Family of Physicians to Vision-Driven Scientist | Barry’s MD-PhD Journey | Leadership Through Critical Thinking & Resilience | The Journey From Academia to Industry

25 Nov 2024

Contributed by Lukas

Part 1 of 4: Jon Chee hosts Barry Ticho, Founder of Verve Therapeutics and Chief Medical Officer at Stoke Therapeutics, a biotech company addressing t...

🧬Chris Moxham - Transcripta Bio - Part 4 | Partnership Strategies with Big Pharma | Balancing Science & Business | Leveraging AI in Drug Discovery | The Vision for Transcripta Bio

21 Nov 2024

Contributed by Lukas

Part 4 of 4: Jon Chee hosts Chris Moxham, Co-Founder, CEO, and CSO of Transcripta Bio—a pioneering biotech company accelerating drug discovery to im...

🧬Chris Moxham - Transcripta Bio - Part 3 | Embracing the Startup Challenge | Mastering Science-to-Business Communication | Building a Scalable Discovery Engine | Leveraging AI & Genetics in Drug Development

18 Nov 2024

Contributed by Lukas

Part 3 of 4: Jon Chee hosts Chris Moxham, Co-Founder, CEO, and CSO of Transcripta Bio—a pioneering biotech company accelerating drug discovery to im...

🧬Chris Moxham - Transcripta Bio - Part 2 | From Eli Lilly Recruit to NYC Lab Builder | Leading High-Stakes Drug Discovery | Pioneering Quantitative Biology | "Making the Trains Run on Time"

14 Nov 2024

Contributed by Lukas

Part 2 of 4: Jon Chee hosts Chris Moxham, the Co-Founder, CEO, and CSO of Transcripta Bio, a pioneering biotech company charting a faster path in drug...

🧬Chris Moxham - Transcripta Bio - Part 1 | From Long Island to Biotech Pioneer | Cornell's Pivotal Role in Research Passion | Strategic Leap to Pharma Industry | Cultivating Effective Leadership in Science

11 Nov 2024

Contributed by Lukas

Part 1 of 4: Jon Chee hosts Chris Moxham, the Co-Founder, CEO, and CSO of Transcripta Bio, a pioneering biotech company charting a faster path in drug...

🧬Michael Chen - Nuclera - Part 2 | From Grad Student to Biotech CEO | Unique Challenges Combining Science & Business | Developing Breakthrough Products | Building Partnerships with Big Pharma | Creating a Biotech GTM Strategy

07 Nov 2024

Contributed by Lukas

Jon Chee hosts Michael Chen, the Co-Founder and CEO of Nuclera, a biotech company that focuses on bringing rapid protein access to other labs. Micha...

🧬Michael Chen - Nuclera - Part 1 | Influence of a Data-Driven Family | Do the Dishes in a Lab | NIH-Oxford Cambridge Scholarship Program | What Got Us Here Won’t Get Us There

04 Nov 2024

Contributed by Lukas

Part 1 of 2: Jon Chee hosts our latest guest, Michael Chen, the Co-Founder and CEO of Nuclera, a biotech company that focuses on bringing rapid protei...

🧬 Neela Patel - Bonum Therapeutics - Part 4 | Transitioning to Seattle Genetics & Business Development | Insights from Roche’s Acquisition | Building a Transformative Oncology Pipeline with Bonum Therapeutics

31 Oct 2024

Contributed by Lukas

Part 4 of 4: Jon Chee hosts our latest guest, Neela Patel, Chief Business Officer at Bonum Therapeutics who are developing protein therapeutics to b...

🧬 Neela Patel - Bonum Therapeutics - Part 3 | Developing Pipeline Strategy at Poniard Pharmaceuticals | Business & Corporate Development in Oncology | Transitioning from Abbott to AbbVie to Seagen

28 Oct 2024

Contributed by Lukas

Part 3 of 4: Jon Chee hosts our latest guest, Neela Patel, Chief Business Officer at Bonum Therapeutics who are developing protein therapeutics to b...

🧬Neela Patel - Bonum Therapeutics - Part 2 | Leading an Academic Microbiology Lab | The Value of Personal Relationships in the Workplace | Leading a Team & Learning on the Job | The Volatility of an Acquisition

24 Oct 2024

Contributed by Lukas

Part 2 of 4: Jon Chee hosts our latest guest, Neela Patel, Chief Business Officer at Bonum Therapeutics who are developing protein therapeutics to b...

🧬 Neela Patel - Bonum Therapeutics - Part 1 | Growing Up in an Intellectual Household | How One Biology Class Inspired Her | Working With Influential Scientists at DNAX | Pursuing the Intersection of Science & Business

21 Oct 2024

Contributed by Lukas

The Biotech Startups Podcast is brought to you by Excedr. Excedr provides life science startups with equipment leases on founder-friendly terms to acc...

🧬eMalick Njie, Ph.D - Ecotone - Part 4 | Building Ecotone AI to Cure Rare Diseases | Diffusion Transformers in Genomics | Synthetic Genomes for AI Training | Long-Term Vision for Genetic Breakthroughs

17 Oct 2024

Contributed by Lukas

Jon Chee hosts our latest guest, eMalick Njie, CEO of Ecotone AI, a healthcare company that is using AI to find cures for inherited diseases. eMalick ...

🧬 eMalick Njie, Ph.D - Ecotone - Part 3 | Founding an AI-Powered Biotech | Overcoming Challenges & Personal Sacrifices | Importance of Team Alignment | Combining AI, Genetics, & Population Studies

14 Oct 2024

Contributed by Lukas

Part 3 of 4: Jon Chee hosts our latest guest, eMalick Njie, CEO of Ecotone AI, a healthcare company that is using AI to find cures for inherited disea...

🧬eMalick Njie, Ph.D - Ecotone - Part 2 | What is Memory? | Playing “Stump the Professor” | Lab Coat Labs vs Sandals Labs | Wanting to Help People at Scale

10 Oct 2024

Contributed by Lukas

Part 2 of 4: Jon Chee hosts our latest guest, eMalick Njie, CEO of Ecotone AI, a healthcare company that is using AI to find cures for inherited disea...

🧬eMalick Njie, Ph.D - Ecotone - Part 1 | Growing Up in the Gambia | The Unending Book of Neuroscience | Being a Professional Scientist | How to Lose Your MIT Recommendation Letter: 101

07 Oct 2024

Contributed by Lukas

Part 1 of 4: Jon Chee hosts our latest guest, eMalick Njie, CEO of Ecotone AI, a company that is looking to use AI to find cures for rare inherited di...

🧬Barbara Alcaraz Silva - J.P. Morgan - Part 4 | Barbara’s Pivot into Banking | The Power of Mentorship & Resilience | Seizing Unexpected Opportunities | The Challenges of Building a Career in Science & Finance

03 Oct 2024

Contributed by Lukas

Jon Chee hosts our latest guest, Barbara Alcaraz Silva, the Executive Director of Early Stage Life Sciences and Healthcare, Startup Banking at J.P. Mo...

🧬 Barbara Alcaraz Silva - J.P. Morgan - Part 3 | From Academia to Entrepreneurship, Investing, & Advising | Co-Founding a Startup | Challenges of Early-Stage Company Building | Improve Your Investor Pitch & Connect with the Right People

30 Sep 2024

Contributed by Lukas

Part 3 of 4. My guest for this week’s episode is Barbara Alcaraz Silva, Executive Director of Early Stage Life Sciences and Healthcare, Startup Ba...

🧬 Barbara Alcaraz Silva - J.P. Morgan - Part 2 | Mentorship & Research at the Beckman Laser Institute | An Entrepreneurial PhD Experience | Exploring Stem Cell Biology in London | Navigating Networking & Postdoc Opportunities

26 Sep 2024

Contributed by Lukas

Part 2 of 4. My guest for this week’s episode is Barbara Alcaraz Silva, Executive Director of Early Stage Life Sciences and Healthcare, Startup Ba...

🧬 Barbara Alcaraz Silva - J.P. Morgan - Part 1 | Living the American Dream & Emigrating From Mexico | Soaking Up Experiences & Embracing Opportunities | Researching at the Harvard of Mexico | Presenting In Spanish at a National Conference

23 Sep 2024

Contributed by Lukas

Part 1 of 4. My guest for this week’s episode is Barbara Alcaraz Silva, Executive Director of Early Stage Life Sciences and Healthcare, Startup Ba...

🧬 Derek Hennecke - Kincell Bio - Part 4 | Building & Scaling Xcelience | Buy-Side vs. Sell-Side of M&A | The Importance of Continuous Learning | Transition into Investing & Board Member Work

19 Sep 2024

Contributed by Lukas

Part 4 of 4. My guest for this week’s episode is Derek Hennecke, a veteran biotech entrepreneur and board member with over 30 years of experience ...

🧬 Derek Hennecke - Kincell Bio - Part 3 | Starting an Operations Role in Egypt | The Importance of Teamwork | Moving into Biologics & Overseeing GMP Operations | Buying a Business & Founding Xcelience

16 Sep 2024

Contributed by Lukas

Part 3 of 4. My guest for this week’s episode is Derek Hennecke, a veteran biotech entrepreneur and board member with over 30 years of experience ...

🧬 Derek Hennecke - Kincell Bio - Part 2 | Taking Risks and Jumping for the Right Opportunity | The Willingness To Do, Opens Doors | Your Job is More than the Products It is Producing | Building Trust in Other Countries

12 Sep 2024

Contributed by Lukas

Part 2 of 4. My guest for this week’s episode is Derek Hennecke, a veteran biotech entrepreneur and board member with over 30 years of experience ...

🧬 Derek Hennecke - Kincell Bio - Part 1 | Sales Means Having Two Ears and One Mouth | The Support of a Partner Can Make or Break a Career | Skip the MBA

09 Sep 2024

Contributed by Lukas

Part 1 of 4. My guest for this week’s episode is Derek Hennecke, a veteran biotech entrepreneur and board member with over 30 years of experience ...

🧬 Doug Drysdale - Cybin - Part 4 | The Challenges of Running a Public Company | Transforming Psychiatric Treatments Through Psychedelic Compounds | Developing Breakthrough Therapies in Depression & Anxiety

05 Sep 2024

Contributed by Lukas

Part 4 of 4. My guest for this week’s episode is Doug Drysdale, CEO at Cybin. Cybin is a clinical-stage biopharma company on a mission to create s...

🧬 Doug Drysdale - Cybin - Part 3 | Jumping from BD to M&A | Leveraging Debt for Strategic Acquisitions | The Importance of Cultural Fit in Successful Deals | Making an Impact at Norwich, Alvogen, & Pernix Therapeutics

02 Sep 2024

Contributed by Lukas

Part 3 of 4. My guest for this week’s episode is Doug Drysdale, CEO at Cybin. Cybin is a clinical-stage biopharma company on a mission to create s...

🧬 Doug Drysdale - Cybin - Part 2 | Deals Only Get Done in Person | Learning Financing Through a Company’s Hardship | Bureaucracy in the Workplace | How to Educate Yourself to Determine Good Licensing Deals

29 Aug 2024

Contributed by Lukas

Part 2 of 4. My guest for this week’s episode is Doug Drysdale, CEO at Cybin. Cybin is a clinical-stage biopharma company on a mission to create ...

🧬 Doug Drysdale - Cybin - Part 1 | One Teacher Can Change Your Whole Perspective | The Forefront of the Human Genome Project | How Loss Taught Him Not to Take Life For Granted | Learning How to Be Personable in Sales

26 Aug 2024

Contributed by Lukas

Part 1 of 4. My guest for this week’s episode is Doug Drysdale, CEO at Cybin. Cybin is a clinical-stage biopharma company on a mission to create ...

🧬 Noam Solomon - Immunai - Part 4 | How Searching for Investors is Like Finding a Life Partner | Luck In Fundraising | The Optimal Features of the Immune System | The Advice to Take More Risks

22 Aug 2024

Contributed by Lukas

Part 4 of 4. My guest for this week’s episode is Noam Solomon, CEO and co-founder at Immunai, a pioneering biotech company that is comprehensively...

🧬 Noam Solomon - Immunai - Part 3 | Deciphering the Book That is the Human Immune System | Building Immunai’s Team | The Importance of Single Cell Multi-Omics | Big Pharma & Dancing With Gorillas

19 Aug 2024

Contributed by Lukas

Part 3 of 4. My guest for this week’s episode is Noam Solomon, CEO and co-founder at Immunai, a pioneering biotech company that is comprehensively...

🧬 Noam Solomon - Immunai - Part 2 | The Value of Attending Prestigious Institutions | Immunai’s Genesis | AI, Machine Learning, & Their Applications in the Life Sciences | Mapping the Human Immune System

15 Aug 2024

Contributed by Lukas

Part 2 of 4. My guest for this week’s episode is Noam Solomon, CEO and co-founder at Immunai, a pioneering biotech company that is comprehensively...

🧬 Noam Solomon - Immunai - Part 1 | Attending Undergrad at 14 Year Old | How Mathematics Can Make You a Lone Wolf | The Difference Between Noam’s Two PhDs | The Resilience Required for Entrepreneurship

12 Aug 2024

Contributed by Lukas

Part 1 of 4. My guest for this week’s episode is Noam Solomon, CEO and co-founder at Immunai, a pioneering biotech company that is comprehensively...

🧬 Shekhar Mitra - InnoPreneur & P&G - Part 4 | Finding Foundational Intrapreneurship at P&G | Early Innovation in Drug Discovery & Development | Community & Diversity Leadership in Arts & STEM

08 Aug 2024

Contributed by Lukas

Part 4 of 4. My guest for this week’s episode is Shekhar Mitra, former Senior Vice President of Global Innovation and Chief of Innovation at Proct...

🧬 Shekhar Mitra - InnoPreneur & P&G - Part 3 | The First Big Innovation Center in Asia | The Whole Work of Leadership | Noticeability Driven Through Technology | Developing Emotional Drivers

05 Aug 2024

Contributed by Lukas

Part 3 of 4. My guest for this week’s episode is Shekhar Mitra, former Senior Vice President of Global Innovation and Chief of Innovation at Proct...

🧬 Shekhar Mitra - InnoPreneur & P&G - Part 2 | Columbia & Yale: Collaborating with Top Physicists | Moving from Academia to Procter & Gamble | Navigating Challenges, Celebrating Successes | Leading Clinical Trials & Working with the FDA

01 Aug 2024

Contributed by Lukas

Part 2 of 4. My guest for this week’s episode is Shekhar Mitra, former Senior Vice President of Global Innovation and Chief of Innovation at Proct...

🧬 Shekhar Mitra - InnoPreneur & P&G - Part 1 | Growing Up in a Multigenerational Household | Undergraduate Experience at IIT | Groundbreaking Lab Research at Columbia | Diverse Experiences in New York City

29 Jul 2024

Contributed by Lukas

Part 1 of 4. My guest for this week’s episode is Shekhar Mitra, former Senior Vice President of Global Innovation and Chief of Innovation at Proct...

🧬 Nathan Clark - Ganymede - Part 4 | Data Integration & Automation in the Life Sciences | Building a Technical Team & Go-To-Market Motion | Creating Efficient Data Infrastructures | Automating Complex Workflows

25 Jul 2024

Contributed by Lukas

Part 4 of 4. My guest for this week’s episode is Nathan Clark, Founder and CEO of Ganymede. Ganymede is the modern cloud data platform for the lif...

🧬 Nathan Clark - Ganymede - Part 3 | Parallels Between Benchling & Salesforce | Getting Customers to Fully Buy-In | Managing the “Writhing Snake of Data” | Ganymede Achieves Escape Velocity Growth

22 Jul 2024

Contributed by Lukas

Part 3 of 4. My guest for this week’s episode is Nathan Clark, Founder and CEO of Ganymede. Ganymede is the modern cloud data platform for the lif...

🧬 Nathan Clark - Ganymede - Part 2 | Moving from Goldman Sachs to Fintech | Exploring Product Management at Affirm | Leveraging Data & Building Tech Solutions| Impacting Scientific Progress at Benchling

18 Jul 2024

Contributed by Lukas

Part 2 of 4. My guest for this week’s episode is Nathan Clark, Founder and CEO of Ganymede. Ganymede is the modern cloud data platform for the lif...

🧬 Nathan Clark - Ganymede - Part 1 | Early Influence of Entrepreneurs | Developing Passions for Both Finance & Life Sciences | Fundamentals of Trading & Finances | Experiences & Opportunities at Goldman Sachs

15 Jul 2024

Contributed by Lukas

Part 1 of 4. My guest for this week’s episode is Nathan Clark, Founder and CEO of Ganymede. Ganymede is the modern cloud data platform for the lif...

🧬 David Li - Meliora Therapeutics - Part 4 | Mechanism Identification in Biotech | AI & ML in Drug Development | Creating a New Method for Drug Discovery | Fundraising for Meliora | Building a Foundational Startup Team

11 Jul 2024

Contributed by Lukas

Part 4 of 4. My guest for this week’s episode is David Li, CEO and co-founder of Meliora Therapeutics. Meliora's goal is to develop life-saving ca...

🧬 David Li - Meliora Therapeutics - Part 3 | Developing a Blood-Based Lung Cancer Test | The Rifle-Shot Nature of Biotech | Software Vs. Biotech Product Market Fit | The Super Power all Startups Need

08 Jul 2024

Contributed by Lukas

Part 3 of 4. My guest for this week’s episode is David Li, CEO and co-founder of Meliora Therapeutics. Meliora's goal is to develop life-saving ca...

🧬 David Li - Meliora Therapeutics - Part 2 | From Finance to Biotech Entrepreneurship | Building Solid Teams & Navigating Market Dynamics | Lessons in Early-Stage Startups

03 Jul 2024

Contributed by Lukas

Part 2 of 4. My guest for this week’s episode is David Li, CEO and co-founder of Meliora Therapeutics. Meliora's goal is to develop life-saving ca...

🧬 David Li - Meliora Therapeutics - Part 1 | Childhood in China and Kentucky | Early Opportunities in Research & Biology | Benefits of Dual Degrees | Experiences & Opportunities while Investment Banking at Goldman Sachs

01 Jul 2024

Contributed by Lukas

Part 1 of 4. My guest for this week’s episode is David Li, CEO and co-founder of Meliora Therapeutics. Meliora's goal is to develop life-saving ca...

🧬 Mark Kotter - bit.bio - Part 4 | Democratizing Access to Cells & the Evolution of bit.bio | A Financial Journey from Angel Investment to IPO | Building a Tech Bio Platform & Mark’s 10-Year Vision

27 Jun 2024

Contributed by Lukas

Part 4 of 4. My guest for this week’s episode is Mark Kotter, neurosurgeon, stem cell biologist, and CEO and founder of bit.bio. He has also been ...

🧬 Mark Kotter - bit.bio - Part 3 | Success in Academia vs. Industry | Vital Things All Founders Should Know | The Importance of Company Culture | bit.bio & the Operating System of Life

24 Jun 2024

Contributed by Lukas

Part 3 of 4. My guest for this week’s episode is Mark Kotter, neurosurgeon, stem cell biologist, and CEO and founder of bit.bio. Bit.bio is an awa...

🧬 Mark Kotter - bit.bio - Part 2 | Navigating Between the Clinical & Research Worlds | Lessons in Combining Different Fields | The Evolution of Cell Therapies | Transitioning from Academia to Entrepreneurship

20 Jun 2024

Contributed by Lukas

Part 2 of 4. My guest today is Mark Kotter, neurosurgeon, stem cell biologist, and CEO and Founder of bit.bio. Bit.bio is an award-winning human synt...

🧬 Mark Kotter - bit.bio - Part 1 | Childhood Experiences in Different Countries | Overcoming Dyslexia & Developing Math Skills | Pivoting His Career to Science and Medicine | Facilitating Curiosity Via Research & Lab Experiences

17 Jun 2024

Contributed by Lukas

Part 1 of 4. My guest for this week’s episode is Mark Kotter, neurosurgeon, stem cell biologist, and CEO and founder of bit.bio. Bit.bio is an awa...

🧬 Quin Wills - Ochre Bio - Part 4 | Quin’s Journey Through Y Combinator | The Role of Empathy in Team Dynamics | Adapting in a Shifting Biotech Industry | Ochre Bio’s Fundraising Journey & Future Plans

13 Jun 2024

Contributed by Lukas

Part 4 of 4. My guest for this week’s episode is Quin Wills, CSO and Co-Founder of Ochre Bio, a pioneering biotechnology company developing RNA th...

🧬 Quin Wills - Ochre Bio - Part 3 | University of Oxford’s Single Cell Consortium | The Pitfalls of Californian Entrepreneurships | Dinner Table Origins of Ochre Bio | The Laws that Guide Ochre Bio

10 Jun 2024

Contributed by Lukas

Part 3 of 4. My guest for this week’s episode is Quin Wills, CSO and Co-Founder of Ochre Bio, a pioneering biotechnology company developing RNA th...

🧬 Quin Wills - Ochre Bio - Part 2 | Pursuing Dual Masters at Oxford & Cambridge | Moving from Genomics to RNA Research | Balancing Academia & Entrepreneurship | The Challenges of Product-Market Fit in Biotech

06 Jun 2024

Contributed by Lukas

Part 2 of 4. My guest for this week’s episode is Quin Wills, CSO and Co-Founder of Ochre Bio, a pioneering biotechnology company developing RNA th...

🧬 Quin Wills - Ochre Bio - Part 1 | Childhood Moments in Johannesburg | A Passion for Science Grows with an Evolving Society | Academic Experience in Biology and Genetics | Exposure to Bioinformatics and Big Data

03 Jun 2024

Contributed by Lukas

Part 1 of 4. My guest for this week’s episode is Quin Wills, CSO and Co-Founder of Ochre Bio, a pioneering biotechnology company developing RNA th...

🧬 Grant Aarons - FabricNano - Part 3 | Meeting His Co-Founder at Entrepreneur First | Importance of Sales to the Scientific Community | Disrupting the Petrochemical Industry | The Dark Horse of Biology, Synthetic Biology

29 May 2024

Contributed by Lukas

Part 3 of 3. My guest for this week’s episode is Grant Aarons, Co-Founder and CEO of FabricNano, a London-based biotech whose mission is to transf...

🧬 Grant Aarons - FabricNano - Part 2 | The Defensibility of Software Companies | Studying Econometrics at London Business School | Joining Entrepreneur First | Becoming a Biotech Startup CEO & Navigating the Startup Journey

22 May 2024

Contributed by Lukas

Part 2 of 3. My guest for this week’s episode is Grant Aarons, Co-Founder and CEO of FabricNano, a London-based biotech whose mission is to transfo...

🧬 Grant Aarons - FabricNano - Part 1 | How NYC Shaped a Love of Engineering | Benefitting from Great Diversity at Cooper Union | Experiences & Opportunities at the Federal Reserve Bank of New York | Impact of the Economy on Deep Tech

15 May 2024

Contributed by Lukas

Part 1 of 3. My guest for this week’s episode is Grant Aarons, Co-Founder and CEO of FabricNano, a London-based biotech whose mission is to transf...

🧬 Bryan Dechairo - Sherlock Biosciences - Part 3 | Assurex’s Journey From Garage to GeneSight | Keeping a Team Together Through the M&A Process | Building a Diagnostics Company During Covid | What Sherlock & Netflix Have in Common

08 May 2024

Contributed by Lukas

Part 3 of 3. My guest for this week’s episode is Bryan Dechairo, President, CEO, and Director at Sherlock Biosciences, an innovative biotech compa...

🧬 Bryan Dechairo - Sherlock Biosciences - Part 2 | Transitioning From a Small Startup to Pfizer | Big Data's Role in Modern Genetics | Building & Leading Dynamic Teams | The Evolution of Personalized Medicine

01 May 2024

Contributed by Lukas

Part 2 of 3. My guest for this week’s episode is Bryan Dechairo, President, CEO, and Director at Sherlock Biosciences, an innovative biotech compa...

🧬 Bryan Dechairo - Sherlock Biosciences - Part 1 | A Love of Science Blossoming from a 10-Acre Hobby Farm | Experiencing Great Diversity at UC Berkeley | Growth & Enjoyment of Startups | Unexpected Travels to Pursue a Dream Overseas

24 Apr 2024

Contributed by Lukas

Part 1 of 3. My guest for this week’s episode is Bryan Dechairo, President, CEO, and Director at Sherlock Biosciences, an innovative biotech compa...

🧬 Terry Lo - Vizgen - Part 3 | Transitioning to Vizgen From Akoya | What is Spatial Genomics | The Importance of Genetic Mapping | How to Grow Your Company During Turbulent Times

17 Apr 2024

Contributed by Lukas

Part 3 of 3. My guest for this week’s episode is Terry Lo, President and CEO of Vizgen. Vizgen is developing and commercializing the next generati...

🧬 Terry Lo - Vizgen - Part 2 | Terry’s Move from Big Pharma to Diagnostics | Introduction to Spatial Biology | Navigating Regulatory & Reimbursement Challenges in Diagnostics | Balancing Multiple Roles in M&A Negotiations

10 Apr 2024

Contributed by Lukas

Part 2 of 3. My guest for this week’s episode is Terry Lo, President and CEO of Vizgen. Vizgen is developing and commercializing the next generati...

🧬 Terry Lo - Vizgen - Part 1 | Leveraging Passion for Science to Succeed in Finance | Sales Excellence as an Introvert Through Competition | Financial Modeling & Creating Proper Deal Structure | How Not To Be A Jack of All Trades

03 Apr 2024

Contributed by Lukas

Part 1 of 3. My guest for this week’s episode is Terry Lo, President and CEO of Vizgen. Vizgen is developing and commercializing the next generati...

🧬 Mike Stadnisky - Thielsen Capital - Part 3 | Don’t Fake it ‘Til you Make It | Cleaning Your Corporate “Underwear” | Thielsen’s Investment Philosophy | The Critical Importance of Alignment

27 Mar 2024

Contributed by Lukas

Part 3 of 3. My guest for this week’s episode is Mike Stadnisky, Managing Director of Thielsen Capital. Thielsen Capital is a seed-stage financing s...

🧬 Mike Stadnisky - Thielsen Capital - Part 2 | Transitioning from Academia to Business | Breaking Into Business Development | Finding Decision Makers & Champions | Navigating Partnerships & Strategy

20 Mar 2024

Contributed by Lukas

Part 2 of 3. My guest for this week’s episode is Mike Stadnisky, Managing Director of Thielsen Capital. Thielsen Capital is a seed-stage financing...

🧬 Mike Stadnisky - Thielsen Capital - Part 1 | Familial Exposure to Business & Science at a Young Age | The Importance of “Care Before You Share” | Actively Managing Your Time | A PhD is a 10,000 Hour Degree

13 Mar 2024

Contributed by Lukas

Part 1 of 3. My guest for this week’s episode is Mike Stadnisky, Managing Director of Thielsen Capital. Thielsen Capital is a seed-stage financing...

🧬 Martin Brenner - iBio - Part 3 | Transitioning from Big Pharma to Biotech Startups | Lessons in Flexibility, Resilience, & Adaptability | Challenging Long-Held Beliefs in Drug Discovery | The Evolution & Future of iBio

06 Mar 2024

Contributed by Lukas

Part 3 of 3. My guest for this week’s episode is Martin Brenner, CEO and CSO of iBio. iBio uses its AI drug discovery platform to tackle complex a...

🧬 Martin Brenner - iBio - Part 2 | Autonomy at Eli Lilly vs. Structure at Pfizer | Transitioning from AstraZeneca to Merck | Joys & Challenges When Relocating for Work | A Biotech Vision Leading to an Exit From Big Pharma

28 Feb 2024

Contributed by Lukas

Part 2 of 3. My guest for this week’s episode is Martin Brenner, CEO and CSO of iBio. iBio uses its AI drug discovery platform to tackle complex a...

🧬 Martin Brenner - iBio - Part 1 | How Childhood Influences Shape Career Paths | Unexpected Crossovers Between Engineering & Veterinary Clinics | Eli Lilly Nurturing His Professional Development | Communication Can Make or Break Leadership

21 Feb 2024

Contributed by Lukas

Part 1 of 3. My guest for this week’s episode is Martin Brenner, CEO and CSO of iBio. iBio uses its AI drug discovery platform to tackle complex a...

🧬 Jeff Kim - Slingshot Biosciences - Part 3 | Bucking the Status Quo | Raising Capital During Peak COVID | How To Find & Retain Great Talent | Building Partnerships with Distributors

14 Feb 2024

Contributed by Lukas

Part 3 of 3. My guest for this week’s episode is Jeff Kim, co-founder and CEO of Slingshot Biosciences. Slingshot designs and manufactures synthet...

🧬 Jeff Kim - Slingshot Biosciences - Part 2 | Working Toward One Goal In Industry | How Great Loss Prompted Professional Growth | Transitioning From a Basement Lab to a Thriving Company | A 6-Month Startup Idea Exceeding 12 Years of Operation

07 Feb 2024

Contributed by Lukas

Part 2 of 3. My guest for this week’s episode is Jeff Kim, co-founder and CEO of Slingshot Biosciences. Slingshot designs and manufactures synthet...